Lupus Research Alliance Encouraged by Lilly Looking at Potential Lupus Drug for COVID-19
April 23, 2020
The Lupus Research Alliance is pleased to share that Eli Lilly and Company entered into an agreement...
Stories & News
New LRA-Supported Study Discovers STAT1, a Highly Specific Target for Potential New Therapy
April 23, 2020
A new study supported by the Lupus Research Alliance discovered a way that harmful immune responses in...
New Data Points Away from Hydroxychloroquine as COVID-19 Treatment
Updated April 23, 2020
The most commonly prescribed treatment for lupus, hydroxychloroquine (best known as Plaquenil) is not effective for...
LRA Proudly Shares First Results from the COVID-19 Global Rheumatology Alliance Registry
April 20,2020
The Lupus Research Alliance is proud to share that the COVID-19 Global Rheumatology Alliance, of which the organization...
Are Autoimmune Diseases Increasing in the US?
April 16, 2020
A recently published study led by Dr. Gregg Dinse provides compelling evidence that proteins found in many...
Research Shows Benefit to Starting Belimumab Sooner Rather Than Later
April 16, 2020
Treating people with lupus earlier with belimumab (Benlysta) may work better than as a last option according...
LRA Salutes RemeGen on FDA Fast-Track Designation for Potential Lupus Treatment
April 16, 2020
The Lupus Research Alliance is pleased to share news that promises to speed up testing and review...
Letter from LRA to Top U.S. Health Officials
April 12, 2020
Today, the Lupus Research Alliance (LRA) Scientific Advisory Board Chair Dr. Gary Koretzky emailed top federal health...
Carta del presidente de LRA Ken Farber sobre la falta de Plaquenil
8 de abril de 2020
Estimado amigo de Lupus Research Alliance:
Como sabrá, debido a la posibilidad de que Plaquenil (hidroxicloroquina)...
Lupus Therapeutics, filial de Lupus Research Alliance, desarrolla un estudio que se enfoca en los pacientes con lupus y la COVID-19
7 de abril de 2020
Nueva York, NY, 7 de abril de 2020 – Lupus Therapeutics, la filial de ensayos...
Lupus and COVID-19:What You Need to Know Webcast on Video
April 3, 2020
The Lupus Research Alliance (LRA) hosted a live webcast April 2, 2020 on COVID-19 for people with...
LRA Urges Congress to Ensure Lupus Patients Maintain Access to Hydroxychloroquine
April 3, 2020
The President and CEO of the LRA, Kenneth Farber wrote personally to Speaker Nancy Pelosi and Leader...